HomeANNX • STO
add
Annexin Pharmaceuticals AB (publ)
Previous close
kr 0.32
Day range
kr 0.30 - kr 0.32
Year range
kr 0.19 - kr 0.91
Market cap
168.08M SEK
Avg Volume
254.17K
P/E ratio
-
Dividend yield
-
Primary exchange
STO
Market news
Financials
Income Statement
Revenue
Net income
| (SEK) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 12.61M | -15.35% |
Net income | -12.35M | 15.10% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -12.56M | 15.40% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (SEK) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 16.34M | -23.71% |
Total assets | 19.04M | -28.87% |
Total liabilities | 5.32M | -33.04% |
Total equity | 13.71M | — |
Shares outstanding | 532.98M | — |
Price to book | 10.50 | — |
Return on assets | -132.35% | — |
Return on capital | -162.48% | — |
Cash Flow
Net change in cash
| (SEK) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -12.35M | 15.10% |
Cash from operations | -10.28M | 18.51% |
Cash from investing | — | — |
Cash from financing | 978.00K | -95.70% |
Net change in cash | -9.30M | -192.01% |
Free cash flow | -5.81M | 21.23% |
About
Founded
2014
Website
Employees
4
